bioAffinity Technologies Reports Third Quarter 2023 Financia

14.11.2023 - bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for the three and nine months ...

Related Keywords

Texas , United States , University Of Texas At San Antonio , American , America , Maria Zannes , Medicare Advisory Panel On Clinical Diagnostic Laboratory , Company As National , Company Annual Report On Form , College Of American Pathologists , Clinical Laboratory Improvement Amendments , Village Oaks Pathology Services On Sept , Us Department Of Defense , Affinity Technologies Inc , American Medical Association , Precision Pathology Laboratory Services , Company Current Reports On Form , Linkedin , Exchange Commission , Medicaid Services , Company Quarterly Reports On Form , Company Cypath Lung , Facebook , Centers For Medicare , Village Oaks Pathology Services , American Pathologists , Current Procedural Terminology , Cypath Lung , National Director , Executive Account Manager , Olympus America , Affinity President , Executive Officer Maria Zannes , Medicare Advisory Panel , Clinical Diagnostic Laboratory , Affinity Technologie , Next Twelve , Path Lung , Affinity Technologies , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Current Reports , Condensed Consolidated Statements , Bioaffinity Technologies Aktie , Ioaffinity Technologies Inc ,